Growth Metrics

Regenerex Pharma (RGPX) Cash from Financing Activities (2010 - 2025)

Regenerex Pharma (RGPX) reported Cash from Financing Activities of $397502.0 for Q3 2025, up 213.24% year-over-year from $126900.0 in Q3 2024, and up 15088.76% on a QoQ basis from -$2652.0 in Q2 2025.

Regenerex Pharma (RGPX) has 14 years of Cash from Financing Activities data on file, last reported at $397502.0 in Q3 2025.

  • Quarterly Cash from Financing Activities rose 213.24% year-over-year to $397502.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $2.5 million (up 632.12% YoY) and the FY2025 annual result came in at $2.3 million, up 392.19% from the prior year.
  • Cash from Financing Activities rose to $397502.0 in Q3 2025 per RGPX's latest filing, from -$2652.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.9 million in Q1 2025 and bottomed at -$2652.0 in Q2 2025.
  • The 5-year median for Cash from Financing Activities is $44530.0 (2022), against an average of $182637.9.
  • Peak annual rise in Cash from Financing Activities reached 3304.01% in 2025, while the deepest fall reached 104.83% in 2025.
  • Tracing RGPX's Cash from Financing Activities over 5 years: stood at $20837.0 in 2021, then surged by 46.85% to $30600.0 in 2022, then soared by 232.04% to $101603.0 in 2023, then surged by 56.25% to $158757.0 in 2024, then surged by 150.38% to $397502.0 in 2025.
  • Per Business Quant, the three latest RGPX Cash from Financing Activities figures stand at $397502.0 (Q3 2025), -$2652.0 (Q2 2025), and $1.9 million (Q1 2025).

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 397,502.00
Sep 30, 2025 397,502.00
Jun 30, 2025 -2,652.00
Jun 30, 2025 -2,652.00
Mar 31, 2025 1.94 Mn
Mar 31, 2025 1.94 Mn
Dec 31, 2024 158,757.00
Dec 31, 2024 158,757.00
Sep 30, 2024 126,900.00
Sep 30, 2024 126,900.00
Jun 30, 2024 54,960.00
Jun 30, 2024 54,960.00
Mar 31, 2024 56,951.00
Mar 31, 2024 56,951.00
Dec 31, 2023 101,603.00
Dec 31, 2023 101,603.00
Sep 30, 2023 113,045.00
Sep 30, 2023 113,045.00
Jun 30, 2023 191,485.00
Jun 30, 2023 191,485.00
Mar 31, 2023 2,956.00
Mar 31, 2023 2,956.00
Dec 31, 2022 30,600.00
Dec 31, 2022 30,600.00
Sep 30, 2022 8,401.00
Sep 30, 2022 8,401.00
Jun 30, 2022 34,100.00
Jun 30, 2022 34,100.00
Mar 31, 2022 6,723.00
Mar 31, 2022 6,723.00
Dec 31, 2021 20,837.00
Dec 31, 2021 20,837.00
Sep 30, 2021 25,155.00
Sep 30, 2021 25,155.00
Jun 30, 2021 21,545.00
Jun 30, 2021 21,545.00
Dec 31, 2020 14,357.00
Dec 31, 2020 14,357.00
Sep 30, 2020 12,475.00
Sep 30, 2020 12,475.00
Jun 30, 2020 6,981.00
Jun 30, 2020 6,981.00
Mar 31, 2020 78,542.00
Mar 31, 2020 78,542.00
Dec 31, 2019 68,293.00
Dec 31, 2019 68,293.00
Jun 30, 2019 67,258.00
Jun 30, 2019 67,258.00
Mar 31, 2019 80,003.00
Mar 31, 2019 80,003.00
Dec 31, 2018 53,395.00
Dec 31, 2018 53,395.00
Sep 30, 2018 167.00
Sep 30, 2018 167.00
Jun 30, 2018 312.00
Jun 30, 2018 312.00
Mar 31, 2018 6,252.00
Mar 31, 2018 6,252.00
Dec 31, 2017 8,062.00
Dec 31, 2017 8,062.00
Sep 30, 2017 6,433.00
Sep 30, 2017 6,433.00
Jun 30, 2017 33,103.00
Jun 30, 2017 33,103.00
Mar 31, 2017 338.00
Mar 31, 2017 338.00
Nov 30, 2014 15,796.00
Nov 30, 2014 15,796.00
Aug 31, 2014 14,007.00
Aug 31, 2014 14,007.00
May 31, 2014 33,000.00
May 31, 2014 33,000.00
Feb 28, 2014 10,000.00
Feb 28, 2014 10,000.00
Nov 30, 2013 1,700.00
Nov 30, 2013 1,700.00
Aug 31, 2013 25,000.00
Aug 31, 2013 25,000.00
May 31, 2013 20,000.00
May 31, 2013 20,000.00
Feb 28, 2013 -1,136.00
Feb 28, 2013 -1,136.00
Nov 30, 2012 19,194.00
Nov 30, 2012 19,194.00
Aug 31, 2012 30,336.00
Aug 31, 2012 30,336.00
May 31, 2012 5,000.00
May 31, 2012 5,000.00
Feb 29, 2012 20,000.00
Feb 29, 2012 20,000.00
Nov 30, 2011 67,182.00
Nov 30, 2011 67,182.00
Aug 31, 2011 402,202.00
Aug 31, 2011 402,202.00
Nov 30, 2010 13,000.00
Nov 30, 2010 13,000.00